United States · Markets & Finance · TheStreet

This Mid-Cap Biotech’s Pullback Just Created a Trade I Can’t Ignore

Published by TheStreet · United States 18 h ago

The stock has fallen about 15% from its October highs. My strategy offers both double-digit upside potential and downside protection.

Read the full article on TheStreet Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (pro.thestreet.com)

Also worth reading

China’s Export Boom Fuels Growth Despite Slump at Home

China's third-quarter economic growth quickens to 4.5% as exports surge, beating estimates

Deutsche Bank targets Asia crypto custody expansion in 2027 as German launch nears

Qubic freezes chain after attacker drains 1.4K wallets with weak seeds

Zoom and big financial firms add ‘Proof of Human’ badges from Sam Altman’s World to stop fraud and deep fakes

America Needs 48,000 Tons of Rare Earth Magnets. It Only Makes 300